BL‐8040 CXCR4 antagonist is safe and demonstrates antileukemic activity in combination with cytarabine for the treatment of relapsed/refractory acute myelogenous leukemia: An open‐... by Borthakur, Gautam, Ofran, Yishai, Tallman, Martin S., Foran, James, Uy, Geoffrey L., DiPersio, John F., Showel, Margaret M., Shimoni, Avichai, Nagler, Arnon, Rowe, Jacob M., Altman, Jessica K., Abraham, Michal, Peled, Amnon, Shaw, Stephen, Bohana‐Kashtan, Osnat, Sorani, Ella, Pereg, Yaron, Foley‐Comer, Adam, Oberkovitz, Galia, Lustig, Tzipi M., Glicko‐Kabir, Irit, Aharon, Arnon, Vainstein‐Haras, Abi, Kadosh, Shaul E., Samara, Emil, Al‐Rawi, Ahmed N., Pemmaraju, Naveen, Bueso‐Ramos, Carlos, Cortes, Jorge E., Andreeff, Michael

Get full text

Early versus delayed treatment with glatiramer acetate: Analysis of up to 27 years of continuous follow-up in a US open-label extension study by Ford, Corey C, Cohen, Jeffrey A, Goodman, Andrew D, Lindsey, John W, Lisak, Robert P, Luzzio, Christopher, Pruitt, Amy, Rose, John, Rus, Horea, Wolinsky, Jerry S, Kadosh, Shaul E, Bernstein-Hanlon, Emily, Stark, Yafit, Alexander, Jessica K

Get full text

Abstract CT177: A multi-center phase 2a trial of the CXCR4 inhibitor motixafortide (BL-8040) (M) in combination with pembrolizumab (P) and chemotherapy (C), in patients with metast... by Hidalgo, Manuel, Macarulla, Teresa, Semenisty, Valerya, Borazanci, Erkut, Feliu, Jaime, Ponz-Sarvise, Mariano, Abad, David Gutierrez, Oberstein, Paul, Alistar, Angela, Muñoz, Andres, Geva, Ravit, Guillén-Ponce, Carmen, Fernandez, Mercedes Salgado, Peled, Amnon, Chaney, Marya, Glicko-Kabir, Irit, Shemesh-Darvish, Liron, Ickowicz, Debby, Sorani, Ella, Kadosh, Shaul E., Vainstein-Haras, Abi, Bockorny, Bruno

Get full text

Immunophenotypic and Single-Cell Transcriptional Profiling of CD34+ Hematopoietic Stem and Progenitor Cells Mobilized with Motixafortide (BL-8040) and G-CSF Versus Plerixafor and G... by Crees, Zachary D., Retting, Michael, Jayasinghe, Reyka G, Stockerl-Goldstein, Keith E., Vainstein, Abi, Sorani, Ella, Ickowicz, Debby, Shemesh-Darvish, Liron, Kadosh, Shaul, DiPersio, John F.

Get full text

Hematopoietic Cell Transplantation of Higher CD34+ Cell Doses and Specific CD34+ Subsets Mobilized with Motixafortide and/or G-CSF Is Associated with Rapid Engraftment - a Post-Hoc... by Crees, Zachary D., Stockerl-Goldstein, Keith E., Retting, Michael, Larson, Sarah M, Illes, Arpad, Milone, Giuseppe, Martino, Massimo, Stiff, Patrick, Sborov, Douglas W., Pereira, Denise L., Micallef, Ivana N., Moreno Jiménez, Gemma, Mikala, Gábor, Paciello Coronel, Maria Liz, Holtick, Udo, Hiemenz, John W., Qazilbash, Muzaffar H., Hardy, Nancy M., Latif, Tahir, García-Cadenas, Irene, Sorani, Ella, Shemesh-Darvish, Liron, Vainstein, Abi, Kadosh, Shaul, DiPersio, John F.

Get full text

Motixafortide (BL-8040) and G-CSF Versus Placebo and G-CSF to Mobilize Hematopoietic Stem Cells for Autologous Stem Cell Transplantation in Patients with Multiple Myeloma: The Gene... by Crees, Zachary D., Stockerl-Goldstein, Keith E., Larson, Sarah, Illés, Árpád, Milone, Giuseppe, Martino, Massimo, Stiff, Patrick, Sborov, Douglas W., Pereira, Denise L., Micallef, Ivana N., Moreno Jiménez, Gemma, Mikala, Gábor, paciello Coronel, Maria liz, Holtick, Udo, Hiemenz, John W., Qazilbash, Muzaffar H., Hardy, Nancy M., Latif, Tahir, García-Cadenas, Irene, Vainstein, Abi, Sorani, Ella, Gliko-Kabir, Irit, Goldstein, Inbal, Kadosh, Shaul, DiPersio, John F.

Get full text